MCT

MCT Meta Cell is an autologous blood-based anti-aging treatment. Plasma- and platelet-based components are separated from the patient’s blood, processed with the MCT system’s light- and heat-based PBM technology, and applied to the skin to support condition, elasticity and texture.

It may be considered for reduced elasticity, rough texture, fine lines, dryness and an overall decline in skin condition. It is intended more for skin regeneration and overall conditioning than for filling a specific area.

Blood is collected and the required autologous components are separated, usually by centrifugation. They are then processed with the MCT device and may be injected into facial skin according to skin condition and treatment goals.

Many skin boosters inject externally manufactured ingredients. MCT Meta Cell instead uses components obtained from the patient’s own blood; suitability depends on skin condition and treatment goals.

This treatment aims to support changes in skin condition and regeneration rather than create immediate volume. The timing varies, and improvements in texture or elasticity may be noticed gradually.

One or multiple sessions may be planned according to skin condition and goals. The appropriate number and interval are determined after assessing aging and recovery.

When injected directly, temporary redness, swelling, small bumps or bruising may occur at injection sites. These usually improve over time, but recovery varies with skin condition and injection method.

Avoid strong irritation while the skin is temporarily sensitive or red. Timing depends on the treatment method and skin condition, so follow the post-treatment instructions.

Avoid strenuous exercise, saunas, heated rooms and excessive alcohol immediately after treatment. Resume normal activities after redness and swelling have settled.

A combined plan may be considered according to skin condition and goals. Whether treatments are performed together or spaced apart should be decided after assessment.

Yes. It uses plasma- and platelet-based components obtained from the patient’s blood. The required components are separated, processed with the MCT system and used for skin treatment.

PRP separates platelet-rich plasma from the patient’s blood. MCT additionally processes autologous blood-based components using light- and heat-based PBM technology.

Confirm the area, extent, product or device, anesthesia, tax, medication and follow-up inclusions. Combined treatments or additional sessions can change the total; obtain an individual quote after examination.